Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 10,000 shares at $54.06 ($538K) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Scheduled sale ($538k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.57 | 5,100 | $273K | 50.8% |
| 2 | $54.06 | 4,900 | $265K | 49.2% |
| Total | $53.81 avg | 10,000 | $538K | 100% |
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |